Antidiuretic effect and complications of chlorpropamide therapy in diabetes insipidus.
D000293:Adolescent; D000328:Adult; D002747:Chlorpropamide / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003397:Craniopharyngioma / Q000150:complications; D003919:Diabetes Insipidus / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D004231:Diuresis / Q000187:drug effects; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007010:Hyponatremia; D007018:Hypopituitarism; D007027:Hypothalamic Diseases; D007030:Hypothalamo-Hypophyseal System / Q000601:surgery; D007684:Kidney Tubules / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D009994:Osmolar Concentration; D011863:Radioimmunoassay; D015499:Renal Tubular Transport, Inborn Errors; D013960:Thyroid Function Tests; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine; D014869:Water Intoxication
D014284:Triiodothyronine; D013006:Growth Hormone; D013974:Thyroxine; D002747:Chlorpropamide